Propanc Biopharma to Acquire $100 Million Worth of Ethereum

BlockBeats News, September 2nd, according to Globenewswire, publicly traded biopharmaceutical company Propanc Biopharma (PPCB) announced plans to buy $100 million worth of Ethereum in the next 12 months.

Propanc CEO James Nathanielsz stated: "The historical returns of Ethereum have caught the attention of our board, so we plan to be one of the few biotech companies leveraging cryptocurrency to enhance shareholder returns, while actively advancing our existing drug pipeline and pursuing value-adding acquisition strategies."